WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pommier, B.
Right arrow Articles by Noble, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pommier, B.
Right arrow Articles by Noble, F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MORPHINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, March 1, 2002, 22(5):2005-2011

Deletion of CCK2 Receptor in Mice Results in an Upregulation of the Endogenous Opioid System

Blandine Pommier1, Françoise Beslot1, Axelle Simon1, Matthieu Pophillat1, Toshimitsu Matsui2, Valérie Dauge1, Bernard P. Roques1, and Florence Noble1

1 Département de Pharmacochimie Moléculaire et Structurale, Institut National de la Santé et de la Recherche Médicale U266-Centre National de la Recherche Scientifique Unité Mixte de Recherche 8600, Unité de Formation et de Recherche des Sciences Pharmaceutiques et Biologiques, 75270 Paris Cedex 06, France, and 2 Third Division Department of Medecine, Kobe University School of Medecine, Chuo-ku Kobe 650-0017, Japan

Stimulation of the brain CCK2 receptor by the C-terminal octapeptide CCK8 of cholecystokinin (CCK) negatively modulates opioid responses. This suggests the existence of physiologically relevant interactions between endogenous CCK and opioid peptides, opening new perspectives particularly in the treatment of pain or drug addiction. CCK2 receptor-deficient mice were used to analyze the incidence of this gene invalidation on opioid system. Compared with wild-type mice, mutants exhibited the following: (1) a hypersensitivity to the locomotor activity induced by inhibitors of enkephalin catabolism or by morphine; (2) a spontaneous hyperalgesia to thermal nociceptive stimulus, which was reversed by previous administration of the NMDA antagonist MK-801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine maleate], and a large reduction in analgesic effects of endogenous or exogenous opioids; and (3) a more severe withdrawal syndrome after chronic morphine treatment. As expected, stimulation of µ, delta , and D2 receptors on brain tissue of wild-type animals induced a dose-dependent decrease in adenylate cyclase activity, whereas a striking mirror effect was observed in mutants. All of these results suggest that the absence, in knock-out mice, of the negative feedback control on the opioid system, normally performed out by CCK2 receptor stimulation, results in an upregulation of this system. These biochemical and pharmacological results demonstrate the critical role played by CCK2 receptors in opioid-dependent responses.

Key words: cholecystokinin; opioid; mutant mice; adenylyl cyclase; binding; behavior


Copyright © 2002 Society for Neuroscience  0270-6474/02/2252005-07$05.00/0


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. J. Weiland, N. J. Voudouris, and S. Kent
CCK2 receptor nullification attenuates lipopolysaccharide-induced sickness behavior
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R112 - R123.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Genetically Modified Animals in Endocrinology
Endocr. Rev., August 1, 2004; 25(4): 673 - 677.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Inoue, M. Mishina, and H. Ueda
Locus-Specific Rescue of GluR{epsilon}1 NMDA Receptors in Mutant Mice Identifies the Brain Regions Important for Morphine Tolerance and Dependence
J. Neurosci., July 23, 2003; 23(16): 6529 - 6536.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-